Oliveda International, Inc. (OLVI) Announces Shipments of Oliveda Products Worth $10,000 to OLVI Shareholders
July 18, 2019 11:35 ET
|
OLIVEDA International, Inc.
SANTA MONICA, CA, July 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health...
Relevium Provides Corporate Update on Its Medical Cannabis Strategy
June 03, 2019 11:31 ET
|
Relevium Technologies Inc
MONTREAL, June 03, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on...
Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision
May 24, 2019 09:29 ET
|
Relevium Technologies Inc
MONTREAL, May 24, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its OTC business...
Relevium Launches the Push and Pull System™, Targeting a New Revenue Stream in the Burgeoning Cosmeceutical Market
February 07, 2019 08:31 ET
|
Relevium Technologies Inc
MONTREAL, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the new launch of the...
AngioSoma Committed to Expanding Cosmeceutical Future
November 08, 2018 09:50 ET
|
AngioSoma, Inc.
New Industry Data and Product Roadmap Align for Optimistic Outlook HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and...
AngioSoma, Inc. Announces Grant of Patent for Flagship Drug
May 14, 2018 12:13 ET
|
AngioSoma, Inc.
HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship...
Entia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products Line
February 24, 2017 16:01 ET
|
Entia Biosciences, Inc.
PORTLAND, Ore., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) announced that it has licensed to GROH BEAUTY CORP of Deerfield Beach, Florida, the exclusive worldwide rights...
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Convoy Therapeutics, Inc.
June 19, 2013 08:30 ET
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwired - Jun 19, 2013) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Convoy Therapeutics, Inc. The...
Oxis International Inc Receives GRAS Status for its Patented L-Ergothioneine Anti-Oxidant
October 10, 2011 08:30 ET
|
OXIS International Inc.
Beverly Hills, California, Oct. 10, 2011 (GLOBE NEWSWIRE) -- Oxis International Inc. (OTC/Bulletin Board: OXIS.OB and Euronext: OXI.PA) today announced that an independent scientific panel of experts...
Sirona Biochem Identifies Depigmenting Cosmetic Agent for Cosmeceuticals Portfolio
July 29, 2011 08:00 ET
|
Sirona Biochem Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 29, 2011) - Sirona Biochem Corp. (TSX VENTURE:SBM) (the "Company"), a biotechnology company specializing in carbohydrate chemistry...